Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J R Potts

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Alimentary Pharmacology & Therapeutics|July 25, 2013
Determinants of long-term outcome in severe alcoholic hepatitisJ R Potts, S Goubet, M A Heneghan, et al.
The American Surgeon|January 1, 1991
Indications for gastric bypass in palliative operations for pancreatic carcinomaJ R Potts, D P Vogt, T Broughan, et al.
Gastrointestinal Endoscopy|November 1, 1988
Necrotizing fasciitis following percutaneous endoscopic gastrostomyD W Haas, P Dharmaraja, J G Morrison, et al.
Journal of Molecular Biology|March 26, 1998
Solution structure of the glycosylated second type 2 module of fibronectinH Sticht, A R Pickford, J R Potts, et al.
Nature Structural Biology|November 1, 1995
High-resolution structural studies of the factor XIIIa crosslinking site and the first type 1 module of fibronectinJ R Potts, I Phan, M J Williams, et al.
The American Surgeon|January 1, 1989
Recent experience with benign biliary stricturesC B Ross, W Z H'Doubler, K W Sharp, et al.
American Journal of Surgery|December 1, 1984
Emergency distal splenorenal shunts for variceal hemorrhage refractory to nonoperative controlJ R Potts, J M Henderson, W J Millikan, et al.
Structure (London, England : 1993)|January 27, 2000
Solution structure of a pair of modules from the gelatin-binding domain of fibronectinA A Bocquier, J R Potts, A R Pickford, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 7, 2000
Preparation of isotopically labeled recombinant fragments of fibronectin for functional and structural study by heteronuclear nuclear magnetic resonance spectroscopyJ R Bright, A R Pickford, J R Potts, et al.
The American Journal of Physiology|August 1, 1996
Anion channel blockers inhibit swelling-activated anion, cation, and nonelectrolyte transport in HeLa cellsJ A Hall, J Kirk, J R Potts, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|July 25, 2013
Determinants of long-term outcome in severe alcoholic hepatitisJ R Potts, S Goubet, M A Heneghan, et al.
The American Surgeon|January 1, 1991
Indications for gastric bypass in palliative operations for pancreatic carcinomaJ R Potts, D P Vogt, T Broughan, et al.
Gastrointestinal Endoscopy|November 1, 1988
Necrotizing fasciitis following percutaneous endoscopic gastrostomyD W Haas, P Dharmaraja, J G Morrison, et al.
Journal of Molecular Biology|March 26, 1998
Solution structure of the glycosylated second type 2 module of fibronectinH Sticht, A R Pickford, J R Potts, et al.
Nature Structural Biology|November 1, 1995
High-resolution structural studies of the factor XIIIa crosslinking site and the first type 1 module of fibronectinJ R Potts, I Phan, M J Williams, et al.
The American Surgeon|January 1, 1989
Recent experience with benign biliary stricturesC B Ross, W Z H'Doubler, K W Sharp, et al.
American Journal of Surgery|December 1, 1984
Emergency distal splenorenal shunts for variceal hemorrhage refractory to nonoperative controlJ R Potts, J M Henderson, W J Millikan, et al.
Structure (London, England : 1993)|January 27, 2000
Solution structure of a pair of modules from the gelatin-binding domain of fibronectinA A Bocquier, J R Potts, A R Pickford, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 7, 2000
Preparation of isotopically labeled recombinant fragments of fibronectin for functional and structural study by heteronuclear nuclear magnetic resonance spectroscopyJ R Bright, A R Pickford, J R Potts, et al.
The American Journal of Physiology|August 1, 1996
Anion channel blockers inhibit swelling-activated anion, cation, and nonelectrolyte transport in HeLa cellsJ A Hall, J Kirk, J R Potts, et al.
Pageof 6